Your session is about to expire
← Back to Search
Procedure
Magnetic Resonance Guided High Intensity Focused Ultrasound for Pancreatic Adenocarcinoma
N/A
Waitlist Available
Led By Pejman Ghanouni
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 week, and monthly for 24 months following treatment
Awards & highlights
Study Summary
This trial is testing a new way to treat pancreatic cancer using high intensity focused ultrasound.
Eligible Conditions
- Pancreatic Adenocarcinoma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 1 week, and monthly for 24 months following treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 week, and monthly for 24 months following treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Measure acceptable ablation percentage
Total frequency and severity of adverse events
Secondary outcome measures
Assess Pain Response assessed by morphine equivalent daily dose (MEDD)
Assess Pain Response assessed by the Brief Pain Inventory (BPI)
Evidence of ablation-induced inflammation
Trial Design
1Treatment groups
Experimental Treatment
Group I: MRgFUS TreatmentExperimental Treatment1 Intervention
The pancreatic tumor will be ablated with magnetic resonance guided focused ultrasound (MRgFUS).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ExAblate 2100
2010
Completed Phase 2
~60
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,386 Previous Clinical Trials
17,334,007 Total Patients Enrolled
Pejman GhanouniPrincipal InvestigatorStanford University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have advanced pancreatic cancer that cannot be removed with surgery.You have moderate to severe upper abdominal pain, rated at least 4 out of 10 in severity on a pain scale.
Research Study Groups:
This trial has the following groups:- Group 1: MRgFUS Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any openings for participants in this research endeavor?
"Clinicaltrials.gov reveals that the recruitment window for this particular study has closed; it was initially posted on November 22nd 2020 and last updated October 25th 2022. Despite this fact, there are still 789 other clinical trials currently enrolling new patients at present."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger